Lazard Asset Management
WGS icon

Lazard Asset Management’s GeneDx Holdings WGS Stock Holding History

Lazard Asset Management’s Portfolio WGS Stock Details WGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.18M Buy
+33,894
New +$3.09M ﹤0.01% 852
2025
Q1 		– Sell
-457
Closed -$35K – 2601
2024
Q4 		$35K Buy
+457
New +$31.9K ﹤0.01% 2034

Other funds holding WGS

CM
Corvex Management New York $2.52B AUM 25.53% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
ZDA
Zweig-DiMenna Associates New York $722M AUM 97.69% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Lazard Asset Management's WGS Position: Q1 2026 in Review

Lazard Asset Management opened a new position in GeneDx Holdings (WGS) in Q1 2026: 33,894 shares worth $2.18M. The stake represents ﹤0.01% of the portfolio and ranks #852 among its holdings. This is a return to the name: Lazard Asset Management previously reported a position in WGS as recently as Q4 2024.

Lazard Asset Management first reported a position in WGS in Q4 2024 and has held it in 2 quarters since. 240 funds tracked by Wall St. Rank hold WGS as of Q1 2026.

  • Lazard Asset Management held 33,894 shares of GeneDx Holdings worth $2.18M as of Q1 2026.
  • GeneDx Holdings was a new Lazard Asset Management position in Q1 2026.
  • GeneDx Holdings made up ﹤0.01% of Lazard Asset Management's portfolio in Q1 2026, its #852 holding.
  • Lazard Asset Management first reported a position in GeneDx Holdings in Q4 2024 and has held it in 2 quarters since.
  • 240 funds tracked by Wall St. Rank held GeneDx Holdings as of Q1 2026.

Based on Lazard Asset Management's 13F filing for Q1 2026, filed 15 May 2026.